Skip to Main Content

Paper Details

Ranibizumab in myopic choroidal neovascularization: the 12-month results from the REPAIR study.
Ophthalmology
79
2013
Author NameAffiliation
Adnan TufailNIHR Moorfields Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation, Trust and UCL Institute of Ophthalmology
  • 1 - 1

Datasets

Release 1.2